CONECTA Trademark

Trademark Overview


On Monday, March 25, 2024, a trademark application was filed for CONECTA with the United States Patent and Trademark Office. The USPTO has given the CONECTA trademark a serial number of 98466226. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, October 8, 2024. This trademark is owned by Montai Health, Inc.. The CONECTA trademark is filed in the Computer & Software Products & Electrical & Scientific Products category with the following description:

Downloadable computer software for use in the pharmaceuticals and healthcare fields, namely, for the research and development of pharmaceutical products and chemical compounds, design of chemical structures, analysis and prediction of biological or chemical activity, and for analysis and prediction of compound in-vivo properties; downloadable software featuring machine learning and artificial intelligence for use in the pharmaceuticals and healthcare fields in connection with pharmaceutical drug discovery and development; downloadable software incorporating machine learning and artificial intelligence model for use in the field of pharmaceuticals and healthcare; providing online non-downloadable software featuring machine learning and artificial intelligence for use in the field of healthcare; providing on-line non-downloadable software featuring machine learning and artificial intelligence for data analysis and data mining in the fields of healthcare, biomedical and genomic research; ...
conecta

General Information


Serial Number98466226
Word MarkCONECTA
Filing DateMonday, March 25, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, October 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDownloadable computer software for use in the pharmaceuticals and healthcare fields, namely, for the research and development of pharmaceutical products and chemical compounds, design of chemical structures, analysis and prediction of biological or chemical activity, and for analysis and prediction of compound in-vivo properties; downloadable software featuring machine learning and artificial intelligence for use in the pharmaceuticals and healthcare fields in connection with pharmaceutical drug discovery and development; downloadable software incorporating machine learning and artificial intelligence model for use in the field of pharmaceuticals and healthcare; providing online non-downloadable software featuring machine learning and artificial intelligence for use in the field of healthcare; providing on-line non-downloadable software featuring machine learning and artificial intelligence for data analysis and data mining in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for drug and chemical analysis in drug discovery and development and for analysis and prediction of compound in-vivo properties; providing online non-downloadable software featuring machine learning and artificial intelligence for diagnostic and therapeutic use and drug response prediction; providing online non-downloadable software using artificial intelligence for use in the pharmaceutical field for discovering and designing compounds and small molecules; providing on-line non-downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks; scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics, healthcare, biomedical and genomic research; scientific research, namely, research and analysis services using artificial intelligence and machine learning in the scientific fields of analytics, pharmaceutical, healthcare, biomedical and genomic research
In Another Form StatementThe mark was first used anywhere in a different form other than that sought to be registered at least as early as
In Another Form StatementThe mark was first used anywhere in a different form other than that sought to be registered at least as early as

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateFriday, August 23, 2024
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMONTAI THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142

Party NameMontai Health, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, March 25, 2024NEW APPLICATION ENTERED
Wednesday, May 8, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, August 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 3, 2024ASSIGNED TO EXAMINER
Tuesday, October 8, 2024NON-FINAL ACTION E-MAILED
Tuesday, October 8, 2024NON-FINAL ACTION WRITTEN
Tuesday, October 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED